Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for GeneDx Holdings Corp. (WGS:NASDAQ), powered by AI.
GeneDx Holdings Corp. is currently trading at $34.51. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for GeneDx Holdings Corp. on Alpha Lenz.
GeneDx Holdings Corp.'s P/E ratio is -17.7.
“GeneDx Holdings Corp. trades at a P/E of -17.7 (undervalued) with modest ROE of -22.1%. 3Y revenue CAGR of 12.9% highlights clear growth momentum.”
Ask for details →Genedx Holdings Corp is primarily engaged in the complex field of genetic testing and diagnostics. The company focuses on providing unparalleled insights into human genetics, offering a broad array of genomic-based services. These services include clinical diagnostic testing and genomic analyses that play a critical role in personalized medicine. Serving healthcare providers, academic researchers, and pharmaceutical companies, Genedx Holdings Corp leverages its advanced technology platforms to enhance the understanding of genetic and hereditary disorders. The company's extensive test catalog aids in identifying rare and complex genetic conditions, supporting early diagnosis and informed treatment decisions. In the ever-growing biotech industry, Genedx Holdings Corp holds a pivotal position by contributing valuable genetic insights that can lead to groundbreaking therapeutic developments. Its emphasis on precision medicine underscores its importance in modern healthcare, as it helps pave the way for more tailored and effective healthcare solutions.
“GeneDx Holdings Corp. trades at a P/E of -17.7 (undervalued) with modest ROE of -22.1%. 3Y revenue CAGR of 12.9% highlights clear growth momentum.”
Ask for details →GeneDx Holdings Corp. (ticker: WGS) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 1,000 employees. Market cap is $928M.
The current price is $34.51 with a P/E ratio of -17.75x and P/B of 3.78x.
ROE is -22.10% and operating margin is -7.60%. Annual revenue is $305M.